- STAT+: Does Revolution Medicines’ pancreatic cancer drug have even greater potential?Revolution Medicines' pancreatic cancer drug has not yet been approved — and already talk has shifted to how (and when) its use might be expanded.STAT · 1mo ago↗ source
- Male puberty is understudied — but when it starts may predict long-term health risksDue to a significant gender gap, far less is known about the health risks of early or late puberty onset among boys than girls.STAT · 1mo ago↗ source
- What happens at a longevity festival?What happens at a longevity festival? On this week's STATus Report, Alex Hogan gets a dispatch from STAT's Sarah Todd.STAT · 1mo ago↗ source